Patient-Centered Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Patient-Centered Trials in Brazil

Patient-Centered Trials in Brazil – Human Trials CRO

Clinical trials are fundamental in advancing medical research and discovering innovative treatments. In recent years, there has been a growing focus on patient-centered trials, which prioritize the active involvement of patients throughout the research process.

Brazil, with its vast population, diverse demographics, and expanding healthcare infrastructure, has emerged as an ideal location for conducting patient-centered trials. This blog explores the significance of patient-centered trials in Brazil and highlights the benefits they offer to participants and the healthcare ecosystem as a whole.

The Significance of Patient-Centered Trials

Patient-centered trials represent a paradigm shift from traditional research models by placing patients at the center of the study design, implementation, and decision-making process. These trials aim to address the unique needs and perspectives of patients, ensuring that research outcomes are more relevant and applicable to their lives.

Patient-centered trials empower individuals to actively participate in their healthcare decisions, fostering a sense of ownership, collaboration, and trust between researchers and participants.

Advantages of Conducting Patient-Centered Trials in Brazil

Brazil is renowned for its diverse population, encompassing a wide range of ethnicities, genetic backgrounds, and socioeconomic statuses. This diversity provides an excellent opportunity for conducting patient-centered trials that capture the variations in treatment response across different subpopulations.

By including a representative sample of patients, these trials can generate more inclusive and comprehensive research outcomes. Patient-centered trials in Brazil contribute to the development of personalized medicine, where treatments can be tailored to meet the specific needs of diverse patient groups.

Burden of Disease and Access to Participants

Brazil faces significant healthcare challenges, including a high burden of disease. The country has a prevalence of conditions such as cardiovascular diseases, diabetes, cancer, and infectious diseases. Conducting patient-centered trials in Brazil allows researchers to address the specific healthcare needs of the local population, develop targeted interventions, and explore preventive measures.

Furthermore, Brazil’s extensive healthcare infrastructure and network of research institutions provide access to a large pool of potential participants, facilitating efficient recruitment and enrollment processes.

Patient-Centered Trials in Brazil

Patient-Centered Trials in Brazil

Patient-Centered Trials in Brazil

Robust Healthcare Infrastructure

Brazil has made substantial investments in its healthcare infrastructure, including the establishment of research centers, hospitals, and clinics across the country. This robust infrastructure provides a solid foundation for conducting patient-centered trials, ensuring access to state-of-the-art facilities, expertise, and resources for data collection, patient monitoring, and follow-up.

Collaborations between local institutions, international researchers, and pharmaceutical companies can leverage Brazil’s healthcare infrastructure to conduct high-quality trials that benefit both the local population and global medical advancements.

Benefits for Participants

Patient-centered trials empower participants by involving them in the decision-making process. By including patients in study design and protocol development, their experiences, perspectives, and preferences are taken into account, leading to treatments that align with their needs.

Active participation fosters a sense of empowerment, as participants become partners in their own healthcare journey, with their input directly shaping research outcomes.

Participating in patient-centered trials often grants individuals access to innovative treatments that may not be readily available through standard medical channels. These trials provide participants with the opportunity to explore alternative options and potentially benefit from breakthroughs in medical science.

Access to cutting-edge treatments through patient-centered trials can positively impact health outcomes and quality of life for participants.

Enhanced Healthcare Support

Patient-centered trials typically offer comprehensive healthcare support to participants. This includes regular check-ups, close monitoring, and collaboration between healthcare professionals and participants. The multidisciplinary approach ensures that participants receive thorough medical care throughout the trial duration.

Additionally, participants often have access to a supportive network of healthcare experts who provide guidance, education, and emotional support beyond the trial itself. This personalized care contributes to improved participant well-being and ensures that their healthcare needs are addressed holistically.


Patient-centered trials in Brazil offer significant benefits for both participants and the healthcare ecosystem as a whole. By actively involving patients in the research process, these trials ensure that interventions are tailored to their needs, preferences, and unique circumstances.

Brazil’s diverse population, burden of disease, and robust healthcare infrastructure make it an ideal setting for conducting patient-centered trials. The data generated from these trials contributes to medical advancements, personalized medicine, and the improvement of healthcare practices.

Furthermore, patient-centered trials in Brazil have the potential to address healthcare disparities, improve accessibility, and strengthen research collaborations. Through patient-centered trials, Brazil is at the forefront of advancing healthcare, empowering participants, and driving progress towards a patient-centric healthcare system.

Patient-Centered Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Patient-Centered Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Patient-Centered Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Patient-Centered Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Patient-Centered Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Patient-Centered Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Patient-Centered Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Patient-Centered Trials in Brazil

The Cohortias Team

Patient-Centered Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Patient-Centered Trials in Brazil

Network & Partnerships